Structure Therapeutics, Inc. Earnings

Structure Therapeutics, Inc.’s revenue fell -100% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Structure Therapeutics, Inc. has generated NaN% jump in its revenue since last 3-months.

Structure Therapeutics, Inc.’s net profit jumped 190.47% since last year same period to $33Mn in the Q4 2025. On a quarterly growth basis, Structure Therapeutics, Inc. has generated 150.23% jump in its net profits since last 3-months.

Structure Therapeutics, Inc.’s net profit margin jumped +Inf% since last year same period to +Inf% in the Q4 2025. On a quarterly growth basis, Structure Therapeutics, Inc. has generated NaN% jump in its net profit margins since last 3-months.

Structure Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -25% fall from last quarter’s estimates.

Structure Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.35.

Structure Therapeutics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Structure Therapeutics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.